Vestibular MigraineVR-VMNCT07493005
Virtual Reality-Based Vestibular Rehabilitation in Vestibular Migraine
A study testing Home-Based Vestibular Rehabilitation and Virtual Reality-Based Vestibular Rehabilitation in people with Vestibular Migraine, run by Ege University at 1 site in Turkey (Türkiye).
Trial summary
Vestibular migraine (VM) is a common neurological condition characterized by recurrent episodes of dizziness, vertigo, and balance problems, often accompanied by migraine symptoms. These symptoms can significantly impair daily functioning and quality of life. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Vestibular Migraine
- What is being tested?
- Home-Based Vestibular Rehabilitation and Virtual Reality-Based Vestibular Rehabilitation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Mar 2025to 1 Feb 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Diagnosis of definite vestibular migraine according to the International Classification of Headache Disorders, 3rd edition (ICHD-3)
- Age between 18 and 60 years
- Confirmation of vestibular migraine diagnosis using a validated diagnostic scale
- Not receiving acute pharmacological treatment for vestibular migraine at the time of enrollment
- Ability to perform activities of daily living independently
- No visual impairment or ocular disease that would interfere with assessment or rehabilitation
- Ability to understand and comply with study procedures
- Provision of written informed consent
Who cannot join
- Medical contraindications to head movements required for vestibular rehabilitation (e.g., severe cervical disorders)
- Intolerance to virtual reality equipment or conditions preventing its use
- Presence of severe comorbid conditions (e.g., life-threatening disease, severe cognitive impairment, neurological disorder, or severe psychiatric disorder)
- Presence of central nervous system disorders
- Diagnosis of vestibular disorders other than vestibular migraine
- Inability or unwillingness to perform home-based or virtual reality-based vestibular rehabilitation
- Incomplete participation in required assessment procedures
- Physical disability preventing independent walking
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Evaluation of the Effectiveness of Virtual Reality-Based Vestibular Rehabilitation in Patients With Vestibular Migraine: A Randomized Controlled Trial
Vestibular migraine (VM) is a common neurological condition characterized by recurrent episodes of dizziness, vertigo, and balance problems, often accompanied by migraine symptoms. These symptoms can significantly impair daily functioning and quality of life. Vestibular rehabilitation (VR) is a non-pharmacological treatment approach aimed at improving balance, reducing dizziness, and promoting central compensation mechanisms.
This randomized controlled trial aims to evaluate the effectiveness of virtual reality (VR)-based vestibular rehabilitation in patients with vestibular migraine. Participants diagnosed with definite VM will be randomly assigned to two groups: one group will receive a conventional home-based vestibular rehabilitation program, while the other group will receive the same home-based program in addition to a clinic-based virtual reality rehabilitation program.
Read more
The intervention will last for four weeks. Clinical outcomes will be assessed before and after the intervention using both objective and subjective measures, including functional vestibulo-ocular reflex (VOR) performance, postural control, balance, dizziness severity, psychological status, and quality of life.
The study aims to determine whether adding virtual reality-based rehabilitation to conventional home exercises provides additional benefits in improving balance, reducing symptoms, and enhancing functional outcomes in patients with vestibular migraine.
Read the detailed description
Vestibular migraine (VM) is one of the most common causes of recurrent vertigo and dizziness, characterized by episodic vestibular symptoms associated with migraine features. In addition to vertigo, patients frequently report imbalance, spatial disorientation, and functional limitations that significantly impair quality of life. Although pharmacological treatments are widely used, non-pharmacological approaches such as vestibular rehabilitation (VR) have gained increasing attention for managing persistent vestibular symptoms.
Vestibular rehabilitation is based on mechanisms of central neuroplasticity, including adaptation, habituation, and substitution, aiming to improve gaze stability, postural control, and functional mobility. Previous studies have demonstrated that conventional home-based VR programs can reduce dizziness severity and improve balance performance in patients with vestibular disorders, including VM. However, adherence, motivation, and the ability to systematically expose patients to controlled sensory conflicts remain challenging in traditional rehabilitation approaches.
Virtual reality (VR)-based rehabilitation has emerged as an innovative tool that allows patients to interact with controlled, immersive environments that can systematically manipulate visual and proprioceptive inputs. By inducing sensory conflict in a safe and controlled setting, VR-based interventions may enhance vestibular compensation and improve postural control more effectively than conventional methods. Despite these advantages, the effectiveness of VR-based vestibular rehabilitation specifically in patients with vestibular migraine has not been sufficiently investigated.
The present study is designed as a prospective, randomized, single-blind controlled trial to evaluate the effectiveness of adding virtual reality-based vestibular rehabilitation to a conventional home-based VR program in patients with vestibular migraine. Participants diagnosed with definite VM according to the International Classification of Headache Disorders (ICHD-3) criteria will be recruited and randomly assigned to one of two groups: (1) a control group receiving only a home-based individualized vestibular rehabilitation program, and (2) an intervention group receiving both home-based VR and additional clinic-based virtual reality rehabilitation.
The rehabilitation program will be conducted over a four-week period. The home-based program will include adaptation (vestibulo-ocular reflex exercises), habituation, substitution, and balance training exercises tailored to individual symptom profiles. The virtual reality-based intervention will consist of structured tasks such as optokinetic stimulation, head-eye coordination training, target tracking, limits of stability exercises, optical flow exposure, spatial navigation, and simulated environmental challenges.
Outcome measures will be assessed before and after the intervention using both objective and subjective tools. Objective assessments will include functional head impulse test (fHIT), sensory organization test (SOT), and limits of stability (LOS). Subjective and functional measures will include visual analog scale (VAS) for dizziness and balance, Dizziness Handicap Inventory (DHI), Vestibular Disorders Activities of Daily Living Scale (VADL), Functional Gait Assessment (FGA), Dynamic Gait Index (DGI), Activities-specific Balance Confidence Scale (ABC), and Hospital Anxiety and Depression Scale (HADS).
The primary aim of this study is to determine whether the addition of virtual reality-based vestibular rehabilitation provides superior improvements in balance, dizziness severity, and functional outcomes compared to conventional home-based rehabilitation alone. Secondary aims include evaluating changes in vestibulo-ocular reflex function, postural control, psychological status, and quality of life.
This study is expected to provide evidence for the clinical effectiveness of virtual reality-based vestibular rehabilitation in vestibular migraine and contribute to the development of more targeted and engaging rehabilitation strategies for this patient population.
- Conditions
- Vestibular Migraine
- Being tested
- Home-Based Vestibular Rehabilitation, Virtual Reality-Based Vestibular Rehabilitation
- Keywords
- Vestibular Migraine, Virtual Reality, Vestibular Rehabilitation, Balance, Dizziness, Functional Outcomes, Randomized Controlled Trial
- Medical subject headings
- Dizziness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Home-Based Vestibular RehabilitationBehavioural
Intervention 1 - Home-Based Vestibular Rehabilitation
This intervention consists of an individualized home-based vestibular rehabilitation program designed according to each participant's symptom profile. The program includes adaptation exercises (vestibulo-ocular reflex training), habituation exercises targeting motion sensitivity, substitution strategies, and balance training. Participants will be instructed to perform the exercises three times daily, with multiple repetitions, over a four-week period. The program will be explained and demonstrated by a clinician, and participants will be provided with written and visual instructions. Adherence will be monitored through regular follow-up and weekly contact.
Virtual Reality-Based Vestibular RehabilitationBehavioural
This intervention consists of a clinic-based virtual reality-based vestibular rehabilitation program administered in addition to the home-based program. Participants will attend supervised sessions twice per week for four weeks, with each session lasting approximately 30 minutes. The virtual reality program includes structured tasks such as optokinetic stimulation, head-eye coordination training, target tracking, limits of stability exercises, optical flow exposure, spatial navigation, and simulated environments. These tasks are designed to induce controlled sensory conflict, enhance vestibular compensation, and improve postural control and functional balance in a safe and interactive environment.
| Study group | Role | What they receive |
|---|---|---|
| Home-Based Vestibular Rehabilitation | Active comparator | Participants in this group will receive an individualized home-based vestibular rehabilitation program. The program will include adaptation exercises (vestibulo-ocular reflex training), habituation exercises, substitution strategies, and balance training tailored to the patient's symptoms. Participants will be instructed to perform the exercises daily, three times per day, over a period of four weeks. Compliance will be monitored through regular follow-up and communication. Receives: Behavioral: Home-Based Vestibular Rehabilitation |
| Virtual Reality-Based Vestibular Rehabilitation + Home-Based Vestibular Rehabilitation | Experimental | Participants in this group will receive the same individualized home-based vestibular rehabilitation program as the control group. In addition, they will undergo clinic-based virtual reality-based vestibular rehabilitation sessions twice per week for four weeks. The virtual reality program will include tasks such as optokinetic stimulation, head-eye coordination, target tracking, limits of stability training, optical flow exposure, spatial navigation, and simulated environments designed to induce controlled sensory conflict and improve balance and postural control. Receives: Behavioral: Virtual Reality-Based Vestibular Rehabilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in balance performance measured by Sensory Organization Test (SOT)
Postural control will be assessed using the Sensory Organization Test (SOT), which evaluates the participant's ability to maintain balance under different sensory conditions by integrating visual, vestibular, and somatosensory inputs.
Measured: Baseline and 4 weeks
Change in functional vestibulo-ocular reflex performance measured by the Functional Head Impulse Test (fHIT)
Functional vestibulo-ocular reflex performance will be assessed using the Functional Head Impulse Test (fHIT), which evaluates gaze stabilization during rapid head movements.
Measured: Baseline and 4 weeks
Change in dynamic balance measured by the Limits of Stability test (LOS)
Dynamic balance will be assessed using the Limits of Stability (LOS) test, which measures the ability to voluntarily shift the center of gravity within the base of support without losing balance.
Measured: Baseline and 4 weeks
Secondary outcomes (8)
Change in dizziness severity measured by the Visual Analog Scale (VAS)
Dizziness severity will be assessed using a Visual Analog Scale (VAS). Participants will rate the severity of dizziness experienced during the previous week on a 10-cm scale ranging from 0 to 10, where 0 indicates no dizziness and 10 indicates the worst possible dizziness. Higher scores indicate greater symptom severity.
Measured: Baseline and 4 weeks
Change in balance-related symptom severity measured by the Visual Analog Scale (VAS)
Balance-related symptom severity will be assessed using a Visual Analog Scale (VAS). Participants will rate the severity of imbalance experienced during the previous week on a 10-cm scale ranging from 0 to 10, where 0 indicates no imbalance and 10 indicates the worst possible imbalance. Higher scores indicate greater symptom severity.
Measured: Baseline and 4 weeks
Change in dizziness-related disability measured by the Dizziness Handicap Inventory (DHI)
Dizziness-related disability will be assessed using the Dizziness Handicap Inventory (DHI), a 25-item self-reported questionnaire evaluating the functional, emotional, and physical impact of dizziness. The total score ranges from 0 to 100, with higher scores indicating greater perceived disability.
Measured: Baseline and 4 weeks
Change in activities of daily living measured by the Vestibular Disorders Activities of Daily Living Scale (VADL)
Functional limitations in daily life will be assessed using the Vestibular Disorders Activities of Daily Living Scale (VADL), which evaluates the impact of vestibular symptoms on functional, ambulatory, and instrumental daily activities. The scale ranges from 1 to 10, with higher scores indicating greater functional limitation.
Measured: Baseline and 4 weeks
Change in functional gait performance measured by the Functional Gait Assessment (FGA)
Functional gait performance will be assessed using the Functional Gait Assessment (FGA), which evaluates postural stability during various walking tasks. The total score ranges from 0 to 30, with higher scores indicating better gait performance.
Measured: Baseline and 4 weeks
Change in dynamic gait performance measured by the Dynamic Gait Index (DGI)
Dynamic gait performance will be assessed using the Dynamic Gait Index (DGI), which evaluates gait, balance, and fall risk during functional walking tasks. The total score ranges from 0 to 24, with higher scores indicating better mobility and balance performance.
Measured: Baseline and 4 weeks
Change in balance confidence measured by the Activities-specific Balance Confidence Scale (ABC Scale)
Balance confidence will be assessed using the Activities-specific Balance Confidence Scale (ABC), a self-reported measure of confidence in maintaining balance during daily activities. The total score ranges from 0 to 100%, with higher scores indicating greater balance confidence.
Measured: Baseline and 4 weeks
Change in anxiety and depression symptoms measured by the Hospital Anxiety and Depression Scale (HADS)
Psychological status will be assessed using the Hospital Anxiety and Depression Scale (HADS), a self-reported questionnaire evaluating symptoms of anxiety and depression. The total score ranges from 0 to 42, with higher scores indicating greater psychological distress. The scale also includes anxiety (HADS-A) and depression (HADS-D) subscales, each ranging from 0 to 21.
Measured: Baseline and 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Mar 2026
- Study start1 Mar 2025
- Primary completion1 Nov 2025
- Study completion1 Feb 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Vestibular MigraineStudies of the same condition, open and under way.
- More trials run by Ege UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ege University
- Sponsor type
- University, hospital or other
- Collaborators
- The Scientific and Technological Research Council of Turkey
- Responsible party
- Principal investigator, Gulce Kirazli, Ege University
- Investigators
- Gulce Kirazli, PhD, Principal investigator, Ege University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07493005
- Sponsor's protocol ID
- 324S720
- Other IDs
- 324S720
- Acronym
- VR-VM
- Status last verified
- Mar 2026
- First submitted
- 19 Mar 2026
- Last updated
- 27 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Kirazli G, Uzumcugil H, Kapusizoglu S, Cinar E, Ozdemir HN, Saruhan Durmaz G, Kaya I, Kirazli T, Gokcay F, Celebisoy N. Virtual Reality-Based Vestibular Rehabilitation for Vestibular Migraine: A Randomized Trial. Laryngoscope. 2026 Aug 19. doi: 10.1002/lary.70814. Online ahead of print.
PubMed 42618982
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Effectiveness of Virtual Reality-Based Vestibular Rehabilitation in Patients With Vestibular Migraine: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07493005
- Acronym / sponsor ID
- VR-VM / 324S720
- Conditions
- Vestibular Migraine
- Keywords
- Vestibular Migraine, Virtual Reality, Vestibular Rehabilitation, Balance, Dizziness, Functional Outcomes, Randomized Controlled Trial
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Ege UniversityUniversity, hospital or other
- Collaborators
- The Scientific and Technological Research Council of Turkey
- Study start
- 1 Mar 2025 (actual)
- Primary completion
- 1 Nov 2025 (actual)
- Study completion
- 1 Feb 2026 (actual)
- First posted
- 25 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Vestibular migraine (VM) is a common neurological condition characterized by recurrent episodes of dizziness, vertigo, and balance problems, often accompanied by migraine symptoms. These symptoms can significantly impair daily functioning and quality of life. Vestibular rehabilitation (VR) is a non-pharmacological treatment approach aimed at improving balance, reducing dizziness, and promoting central compensation mechanisms.
This randomized controlled trial aims to evaluate the effectiveness of virtual reality (VR)-based vestibular rehabilitation in patients with vestibular migraine. Participants diagnosed with definite VM will be randomly assigned to two groups: one group will receive a conventional home-based vestibular rehabilitation program, while the other group will receive the same home-based program in addition to a clinic-based virtual reality rehabilitation program.
The intervention will last for four weeks. Clinical outcomes will be assessed before and after the intervention using both objective and subjective measures, including functional vestibulo-ocular reflex (VOR) performance, postural control, balance, dizziness severity, psychological status, and quality of life.
The study aims to determine whether adding virtual reality-based rehabilitation to conventional home exercises provides additional benefits in improving balance, reducing symptoms, and enhancing functional outcomes in patients with vestibular migraine.
Detailed description
Vestibular migraine (VM) is one of the most common causes of recurrent vertigo and dizziness, characterized by episodic vestibular symptoms associated with migraine features. In addition to vertigo, patients frequently report imbalance, spatial disorientation, and functional limitations that significantly impair quality of life. Although pharmacological treatments are widely used, non-pharmacological approaches such as vestibular rehabilitation (VR) have gained increasing attention for managing persistent vestibular symptoms.
Vestibular rehabilitation is based on mechanisms of central neuroplasticity, including adaptation, habituation, and substitution, aiming to improve gaze stability, postural control, and functional mobility. Previous studies have demonstrated that conventional home-based VR programs can reduce dizziness severity and improve balance performance in patients with vestibular disorders, including VM. However, adherence, motivation, and the ability to systematically expose patients to controlled sensory conflicts remain challenging in traditional rehabilitation approaches.
Virtual reality (VR)-based rehabilitation has emerged as an innovative tool that allows patients to interact with controlled, immersive environments that can systematically manipulate visual and proprioceptive inputs. By inducing sensory conflict in a safe and controlled setting, VR-based interventions may enhance vestibular compensation and improve postural control more effectively than conventional methods. Despite these advantages, the effectiveness of VR-based vestibular rehabilitation specifically in patients with vestibular migraine has not been sufficiently investigated.
The present study is designed as a prospective, randomized, single-blind controlled trial to evaluate the effectiveness of adding virtual reality-based vestibular rehabilitation to a conventional home-based VR program in patients with vestibular migraine. Participants diagnosed with definite VM according to the International Classification of Headache Disorders (ICHD-3) criteria will be recruited and randomly assigned to one of two groups: (1) a control group receiving only a home-based individualized vestibular rehabilitation program, and (2) an intervention group receiving both home-based VR and additional clinic-based virtual reality rehabilitation.
The rehabilitation program will be conducted over a four-week period. The home-based program will include adaptation (vestibulo-ocular reflex exercises), habituation, substitution, and balance training exercises tailored to individual symptom profiles. The virtual reality-based intervention will consist of structured tasks such as optokinetic stimulation, head-eye coordination training, target tracking, limits of stability exercises, optical flow exposure, spatial navigation, and simulated environmental challenges.
Outcome measures will be assessed before and after the intervention using both objective and subjective tools. Objective assessments will include functional head impulse test (fHIT), sensory organization test (SOT), and limits of stability (LOS). Subjective and functional measures will include visual analog scale (VAS) for dizziness and balance, Dizziness Handicap Inventory (DHI), Vestibular Disorders Activities of Daily Living Scale (VADL), Functional Gait Assessment (FGA), Dynamic Gait Index (DGI), Activities-specific Balance Confidence Scale (ABC), and Hospital Anxiety and Depression Scale (HADS).
The primary aim of this study is to determine whether the addition of virtual reality-based vestibular rehabilitation provides superior improvements in balance, dizziness severity, and functional outcomes compared to conventional home-based rehabilitation alone. Secondary aims include evaluating changes in vestibulo-ocular reflex function, postural control, psychological status, and quality of life.
This study is expected to provide evidence for the clinical effectiveness of virtual reality-based vestibular rehabilitation in vestibular migraine and contribute to the development of more targeted and engaging rehabilitation strategies for this patient population.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Home-Based Vestibular Rehabilitation | Active comparator | Behavioral: Home-Based Vestibular RehabilitationParticipants in this group will receive an individualized home-based vestibular rehabilitation program. The program will include adaptation exercises (vestibulo-ocular reflex training), habituation exercises, substitution strategies, and balance training tailored to the patient's symptoms. Participants will be instructed to perform the exercises daily, three times per day, over a period of four weeks. Compliance will be monitored through regular follow-up and communication. |
| Virtual Reality-Based Vestibular Rehabilitation + Home-Based Vestibular Rehabilitation | Experimental | Behavioral: Virtual Reality-Based Vestibular RehabilitationParticipants in this group will receive the same individualized home-based vestibular rehabilitation program as the control group. In addition, they will undergo clinic-based virtual reality-based vestibular rehabilitation sessions twice per week for four weeks. The virtual reality program will include tasks such as optokinetic stimulation, head-eye coordination, target tracking, limits of stability training, optical flow exposure, spatial navigation, and simulated environments designed to induce controlled sensory conflict and improve balance and postural control. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Diagnosis of definite vestibular migraine according to the International Classification of Headache Disorders, 3rd edition (ICHD-3)
- Age between 18 and 60 years
- Confirmation of vestibular migraine diagnosis using a validated diagnostic scale
- Not receiving acute pharmacological treatment for vestibular migraine at the time of enrollment
- Ability to perform activities of daily living independently
Key exclusion criteria (8 listed)
- Medical contraindications to head movements required for vestibular rehabilitation (e.g., severe cervical disorders)
- Intolerance to virtual reality equipment or conditions preventing its use
- Presence of severe comorbid conditions (e.g., life-threatening disease, severe cognitive impairment, neurological disorder, or severe psychiatric disorder)
- Presence of central nervous system disorders
- Diagnosis of vestibular disorders other than vestibular migraine
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Home-Based Vestibular RehabilitationIntervention 1 - Home-Based Vestibular Rehabilitation This intervention consists of an individualized home-based vestibular rehabilitation program designed according to each participant's symptom profile. The program includes adaptation exercises (vestibulo-ocular reflex training), habituation exercises targeting motion sensitivity, substitution strategies, and balance training. Participants will be instructed to perform the exercises three times daily, with multiple repetitions, over a four-week period. The program will be explained and demonstrated by a clinician, and participants will be provided with written and visual instructions. Adherence will be monitored through regular follow-up and weekly contact. | Behavioural | Home-Based Vestibular Rehabilitation |
| Virtual Reality-Based Vestibular RehabilitationThis intervention consists of a clinic-based virtual reality-based vestibular rehabilitation program administered in addition to the home-based program. Participants will attend supervised sessions twice per week for four weeks, with each session lasting approximately 30 minutes. The virtual reality program includes structured tasks such as optokinetic stimulation, head-eye coordination training, target tracking, limits of stability exercises, optical flow exposure, spatial navigation, and simulated environments. These tasks are designed to induce controlled sensory conflict, enhance vestibular compensation, and improve postural control and functional balance in a safe and interactive environment. | Behavioural | Virtual Reality-Based Vestibular Rehabilitation + Home-Based Vestibular Rehabilitation |
Primary outcome
Change in balance performance measured by Sensory Organization Test (SOT)
Time frame: Baseline and 4 weeks
Postural control will be assessed using the Sensory Organization Test (SOT), which evaluates the participant's ability to maintain balance under different sensory conditions by integrating visual, vestibular, and somatosensory inputs.
Change in functional vestibulo-ocular reflex performance measured by the Functional Head Impulse Test (fHIT)
Time frame: Baseline and 4 weeks
Functional vestibulo-ocular reflex performance will be assessed using the Functional Head Impulse Test (fHIT), which evaluates gaze stabilization during rapid head movements.
Change in dynamic balance measured by the Limits of Stability test (LOS)
Time frame: Baseline and 4 weeks
Dynamic balance will be assessed using the Limits of Stability (LOS) test, which measures the ability to voluntarily shift the center of gravity within the base of support without losing balance.
8 secondary outcomes
Change in dizziness severity measured by the Visual Analog Scale (VAS)
Time frame: Baseline and 4 weeks
Change in balance-related symptom severity measured by the Visual Analog Scale (VAS)
Time frame: Baseline and 4 weeks
Change in dizziness-related disability measured by the Dizziness Handicap Inventory (DHI)
Time frame: Baseline and 4 weeks
Change in activities of daily living measured by the Vestibular Disorders Activities of Daily Living Scale (VADL)
Time frame: Baseline and 4 weeks
Change in functional gait performance measured by the Functional Gait Assessment (FGA)
Time frame: Baseline and 4 weeks
Change in dynamic gait performance measured by the Dynamic Gait Index (DGI)
Time frame: Baseline and 4 weeks
Change in balance confidence measured by the Activities-specific Balance Confidence Scale (ABC Scale)
Time frame: Baseline and 4 weeks
Change in anxiety and depression symptoms measured by the Hospital Anxiety and Depression Scale (HADS)
Time frame: Baseline and 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2026.
- Derived from this study: PubMed 42618982Kirazli G, Uzumcugil H, Kapusizoglu S, Cinar E, Ozdemir HN, Saruhan Durmaz G, Kaya I, Kirazli T, Gokcay F, Celebisoy N. Virtual Reality-Based Vestibular Rehabilitation for Vestibular Migraine: A Randomized Trial. Laryngoscope. 2026 Aug 19. doi: 10.1002/lary.70814. Online ahead of print.
- Individual participant dataSharing planned: Undecided
Related trials for Vestibular Migraine
RecruitingEarly Phase 1
Virtual Reality and Biofeedback for Adolescents With Chronic Dizziness
Persistent Postural Perceptual Dizziness, Vestibular Migraine
Not yet recruitingObservational study
Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents
Vestibular Migraine
RecruitingPhase 4
Acute Treatment of Vestibular Migraine by Rimegepant
Vestibular Migraine
Not yet recruiting
Efficacy of Cognitive Behavioral Therapy at Vestibular Migraine
Cognitive Behavioral Therapy to Medical Treatment on Functional Ability of Patients With Vestibular Migraine
Not yet recruitingPhase 4
Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine
Migraine Disorders, Brain, Healthy Adult Participants
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gulce Kirazli, PhD principal investigator
Ege University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Home-Based Vestibular Rehabilitation and Virtual Reality-Based Vestibular Rehabilitation in people with Vestibular Migraine, run by Ege University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in balance performance measured by Sensory Organization Test (SOT) (time frame: Baseline and 4 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07493005, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.